Literature DB >> 9746434

Modulation of VEGF production by pH and glucose in retinal Müller cells.

S E Brooks1, X Gu, P M Kaufmann, D M Marcus, R B Caldwell.   

Abstract

PURPOSE: To investigate the influence of pH and glucose concentration, both of which represent significant biochemical variables in tissue ischemia, on the production of VEGF protein by retinal Müller cells and C6 glioma cells, under normoxic and hypoxic conditions.
METHODS: Rat retinal Müller cells and C6 glioma cells grown in tissue culture monolayers were studied. The effect of pH (range 7.0-8.0) and glucose concentration (0.6-25 mmol/L) on VEGF protein production, under both normoxic and hypoxic conditions, were evaluated by ELISA analysis of the conditioned media. Establishment of significant cell hypoxia was verified by measurement of lactate release into the conditioned media.
RESULTS: Hypoxia caused a 7.9-fold increase in VEGF production in C6 cells at 24 h, and a 3.4-fold increase in Müller cells after 48 h. Under hypoxic conditions, VEGF protein production was increased further by increasing pH and increasing glucose, and decreased by low pH and low glucose. Varying the glucose concentration or pH of the medium did not result in significant induction of VEGF protein production by either cell type under normoxic conditions.
CONCLUSIONS: Both glucose and pH significantly affected VEGF production induced by low oxygen. However, neither exerted a measurable stimulatory effect on VEGF production in normoxic conditions. Coexisting hypoxia and acidosis or hypoglycemia, as might occur in severe tissue ischemia, may render glial cells incapable of effectively upregulating VEGF synthesis, while alkalosis or hyperglycemia may augment hypoxia-induced VEGF production.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9746434     DOI: 10.1076/ceyr.17.9.875.5134

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  11 in total

Review 1.  Glucose, VEGF-A, and diabetic complications.

Authors:  L E Benjamin
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

Review 2.  Causes and effects of heterogeneous perfusion in tumors.

Authors:  R J Gillies; P A Schornack; T W Secomb; N Raghunand
Journal:  Neoplasia       Date:  1999-08       Impact factor: 5.715

Review 3.  Involvement of Müller glial cells in epiretinal membrane formation.

Authors:  Andreas Bringmann; Peter Wiedemann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-05-05       Impact factor: 3.117

4.  A prospective study on hyperglycemia and retinopathy of prematurity.

Authors:  L Mohsen; M Abou-Alam; M El-Dib; M Labib; M Elsada; H Aly
Journal:  J Perinatol       Date:  2014-03-27       Impact factor: 2.521

Review 5.  Retinopathy of prematurity: a review of risk factors and their clinical significance.

Authors:  Sang Jin Kim; Alexander D Port; Ryan Swan; J Peter Campbell; R V Paul Chan; Michael F Chiang
Journal:  Surv Ophthalmol       Date:  2018-04-19       Impact factor: 6.048

6.  Elevated cell proliferation and VEGF production by high-glucose conditions in Müller cells involve XIAP.

Authors:  Y Sun; D Wang; F Ye; D-N Hu; X Liu; L Zhang; L Gao; E Song; D Y Zhang
Journal:  Eye (Lond)       Date:  2013-08-09       Impact factor: 3.775

7.  High Glucose and Glucose Deprivation Modulate Müller Cell Viability and VEGF Secretion.

Authors:  S Vellanki; A Ferrigno; Y Alanis; B S Betts-Obregon; A T Tsin
Journal:  Int J Ophthalmol Eye Sci       Date:  2016-02-15

Review 8.  Association between neonatal hyperglycemia and retinopathy of prematurity: a meta-analysis.

Authors:  Chunyan Lei; Jianan Duan; Ge Ge; Meixia Zhang
Journal:  Eur J Pediatr       Date:  2021-06-11       Impact factor: 3.183

Review 9.  Association between hyperglycemia and retinopathy of prematurity: a systemic review and meta-analysis.

Authors:  Sunny C L Au; Shu-Min Tang; Shi-Song Rong; Li-Jia Chen; Jason C S Yam
Journal:  Sci Rep       Date:  2015-03-13       Impact factor: 4.379

10.  Hyperglycemia as a risk factor for the development of retinopathy of prematurity.

Authors:  Shakir Mohamed; Jeffrey C Murray; John M Dagle; Tarah Colaizy
Journal:  BMC Pediatr       Date:  2013-05-16       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.